The company’s Whoop MG is the subject of a disagreement with the US Food and Drug Administration (FDA) over whether it acts ...

The Boston wearables firm says the software tool doesn't meet the definition of a medical device and shouldn't be regulated ...

According to a formal warning letter issued to the company, the FDA believes the feature amounts to an unapproved medical ...

The company's CEO defended its feature as a wellness tool under the 21st Century Cures Act, combatting the FDA’s claim that it qualifies as a regulated medical device.

The Whoop MG launched in May with a novel Blood Pressure Insights feature. Now, the FDA wants the company to disable it.

Despite the FDA’s requests to remove the blood pressure tracking tool in Whoop’s new fitness tracker, the company has ...

Whoop users who purchase the $359 "Whoop Life" subscription tier can use the BPI feature to get daily insights about their blood pressure, including estimated systolic and diastolic ranges ...

Whoop is not the only wearable manufacturer that's exploring blood pressure monitoring. Omron and Garmin both offer medical blood pressure monitoring with on-demand readings that fall under FDA ...

Whoop users who purchase the $359 "Whoop Life" subscription tier can use the BPI feature to get daily insights about their blood pressure, including estimated systolic and diastolic ranges ...